213 related articles for article (PubMed ID: 23800233)
1. Hepatocellular carcinoma associated with Budd-Chiari syndrome: imaging features and transcatheter arterial chemoembolization.
Liu FY; Wang MQ; Duan F; Fan QS; Song P; Wang Y
BMC Gastroenterol; 2013 Jun; 13():105. PubMed ID: 23800233
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of hepatocellular carcinoma in Egyptian patients with primary Budd-Chiari syndrome.
Sakr M; Abdelhakam SM; Dabbous H; Hamed A; Hefny Z; Abdelmoaty W; Shaker M; El-Gharib M; Eldorry A
Liver Int; 2017 Mar; 37(3):415-422. PubMed ID: 27507647
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma in Budd-Chiari syndrome: characteristics and risk factors.
Moucari R; Rautou PE; Cazals-Hatem D; Geara A; Bureau C; Consigny Y; Francoz C; Denninger MH; Vilgrain V; Belghiti J; Durand F; Valla D; Plessier A
Gut; 2008 Jun; 57(6):828-35. PubMed ID: 18218675
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular carcinoma associated with membranous obstruction of the inferior vena cava: incidence, characteristics, and risk factors and clinical efficacy of TACE.
Gwon D; Ko GY; Yoon HK; Sung KB; Kim JH; Lee SS; Lee JM; Ohm JY; Shin JH; Song HY
Radiology; 2010 Feb; 254(2):617-26. PubMed ID: 20093533
[TBL] [Abstract][Full Text] [Related]
5. Predictive factors for the benefit of triple-drug transarterial chemoembolization for patients with unresectable hepatocellular carcinoma.
He M; Li Q; Shen J; Tan G; Li Q; Lai J; Wei W; Zhang Y; Zou R; Chen M; Guo R; Shi M
Cancer Med; 2019 Aug; 8(9):4200-4213. PubMed ID: 31207163
[TBL] [Abstract][Full Text] [Related]
6. Low specificity of washout to diagnose hepatocellular carcinoma in nodules showing arterial hyperenhancement in patients with Budd-Chiari syndrome.
Van Wettere M; Purcell Y; Bruno O; Payancé A; Plessier A; Rautou PE; Cazals-Hatem D; Valla D; Vilgrain V; Ronot M
J Hepatol; 2019 Jun; 70(6):1123-1132. PubMed ID: 30654065
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular carcinoma in Budd-Chiari syndrome: enhancement patterns at dynamic gadolinium-enhanced T1-weighted MR imaging.
Yang C; Xu K; Zheng J; Ma P; Hu C; Li S; Rong Y; Lu X; Zhang Q; Zu M; Hua R; Zhang L
Cell Biochem Biophys; 2014 Sep; 70(1):661-6. PubMed ID: 24760630
[TBL] [Abstract][Full Text] [Related]
8. Epirubicin is More Effective than Miriplatin in Balloon-Occluded Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma.
Shirono T; Iwamoto H; Niizeki T; Shimose S; Nakano M; Satani M; Okamura S; Noda Y; Kamachi N; Kuromatsu R; Sakai M; Nomiyama M; Kuwano T; Tanaka M; Koga H; Torimura T
Oncology; 2019; 96(2):79-86. PubMed ID: 30293080
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of alpha-fetoprotein status in the outcome of hepatocellular carcinoma after treatment of transarterial chemoembolization.
Wang Y; Chen Y; Ge N; Zhang L; Xie X; Zhang J; Chen R; Wang Y; Zhang B; Xia J; Gan Y; Ren Z; Ye S
Ann Surg Oncol; 2012 Oct; 19(11):3540-6. PubMed ID: 22532305
[TBL] [Abstract][Full Text] [Related]
10. Previous chemoembolization response after transcatheter arterial chemoembolization (TACE) can predict the anti-tumor effect of subsequent TACE with miriplatin in patients with recurrent hepatocellular carcinoma.
Imai N; Ikeda K; Seko Y; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Saitoh S; Suzuki F; Suzuki Y; Arase Y; Kumada H
Oncology; 2011; 80(3-4):188-94. PubMed ID: 21709428
[TBL] [Abstract][Full Text] [Related]
11. C-arm Lipiodol CT in transcatheter arterial chemoembolization for small hepatocellular carcinoma.
Li JJ; Zheng JS; Cui SC; Cui XW; Hu CX; Fang D; Ye LC
World J Gastroenterol; 2015 Mar; 21(10):3035-40. PubMed ID: 25780303
[TBL] [Abstract][Full Text] [Related]
12. Clinical features and etiology of hepatocellular carcinoma arising in patients with membranous obstruction of the inferior vena cava: in reference to hepatitis viral infection.
Matsui S; Ichida T; Watanabe M; Sugitani S; Suda T; Takahashi T; Asakura H
J Gastroenterol Hepatol; 2000 Oct; 15(10):1205-11. PubMed ID: 11106103
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the relationship between hepatocellular carcinoma location and transarterial chemoembolization efficacy.
Miki I; Murata S; Uchiyama F; Yasui D; Ueda T; Sugihara F; Saito H; Yamaguchi H; Murakami R; Kawamoto C; Uchida E; Kumita SI
World J Gastroenterol; 2017 Sep; 23(35):6437-6447. PubMed ID: 29085193
[TBL] [Abstract][Full Text] [Related]
14. Transcatheter arterial chemoembolization combined with interferon-α is safe and effective for patients with hepatocellular carcinoma after curative resection.
Zuo CH; Xia M; Liu JS; Qiu XX; Lei X; Xu RC; Liu HC; Li JL; Li YG; Li QL; Xiao H; Hong Y; Wang XH; Zhu HZ; Wu QF; Burns M; Liu C
Asian Pac J Cancer Prev; 2015; 16(1):245-51. PubMed ID: 25640360
[TBL] [Abstract][Full Text] [Related]
15. Transcatheter arterial chemoembolization in patients with hepatocellular carcinoma and coexisting hepatic cavernous hemangioma.
Chen RC; Lii JM; Chen WT; Tu HY; Chiang LC
Eur Radiol; 2006 Jun; 16(6):1346-50. PubMed ID: 16331460
[TBL] [Abstract][Full Text] [Related]
16. Oxaliplatin and 5-fluorouracil hepatic infusion with lipiodolized chemoembolization in large hepatocellular carcinoma.
Li JH; Xie XY; Zhang L; Le F; Ge NL; Li LX; Gan YH; Chen Y; Zhang JB; Xue TC; Chen RX; Xia JL; Zhang BH; Ye SL; Wang YH; Ren ZG
World J Gastroenterol; 2015 Apr; 21(13):3970-7. PubMed ID: 25852283
[TBL] [Abstract][Full Text] [Related]
17. Clinical and pathological features and surgical treatment of Budd-Chiari syndrome-associated hepatocellular carcinoma.
Wang YD; Xue HZ; Zhang X; Xu ZQ; Jiang QF; Shen Q; Yu M; Li K; Jia M
Chin Med J (Engl); 2013; 126(19):3632-8. PubMed ID: 24112155
[TBL] [Abstract][Full Text] [Related]
18. Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE).
Iezzi R; Cesario V; Siciliani L; Campanale M; De Gaetano AM; Siciliano M; Agnes S; Giuliante F; Grieco A; Pompili M; Rapaccini GL; Gasbarrini A; Bonomo L;
Radiol Med; 2013 Jun; 118(4):555-69. PubMed ID: 23358819
[TBL] [Abstract][Full Text] [Related]
19. [Investigation of bile duct injury after transcatheter arterial chemoembolization].
Wang MQ; Shao RH; Ye HY; Wang ZQ; Wang ZP; Liu FY
Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):609-12. PubMed ID: 16438871
[TBL] [Abstract][Full Text] [Related]
20. Combined Chemoembolization and Radiotherapy Versus Chemoembolization Alone for Hepatocellular Carcinoma Invading the Hepatic Vein or Inferior Vena Cava.
Alrashidi I; Chu HH; Kim JH; Shim JH; Yoon SM; Kim PH; Gwon DI; Ko HK
Cardiovasc Intervent Radiol; 2021 Jul; 44(7):1060-1069. PubMed ID: 33745071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
